Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| GABAergic neuron | 7 studies | 34% ± 21% | |
| endothelial cell | 6 studies | 22% ± 7% | |
| epithelial cell | 6 studies | 29% ± 11% | |
| astrocyte | 5 studies | 25% ± 9% | |
| oligodendrocyte | 5 studies | 25% ± 6% | |
| neuron | 4 studies | 25% ± 7% | |
| glutamatergic neuron | 4 studies | 56% ± 21% | |
| oligodendrocyte precursor cell | 4 studies | 29% ± 9% | |
| interneuron | 4 studies | 42% ± 23% | |
| microglial cell | 3 studies | 19% ± 1% | |
| erythroblast | 3 studies | 27% ± 8% | |
| abnormal cell | 3 studies | 26% ± 6% | |
| intestinal crypt stem cell | 3 studies | 24% ± 6% | |
| transit amplifying cell | 3 studies | 35% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 2443.74 | 1445 / 1445 | 100% | 28.48 | 183 / 183 |
| intestine | 100% | 2257.97 | 966 / 966 | 100% | 38.30 | 527 / 527 |
| ovary | 100% | 2341.82 | 180 / 180 | 100% | 24.38 | 430 / 430 |
| pancreas | 100% | 1470.47 | 328 / 328 | 100% | 21.95 | 178 / 178 |
| prostate | 100% | 2030.21 | 245 / 245 | 100% | 25.45 | 502 / 502 |
| stomach | 100% | 1861.39 | 359 / 359 | 100% | 33.12 | 286 / 286 |
| uterus | 100% | 2306.58 | 170 / 170 | 100% | 26.09 | 459 / 459 |
| breast | 100% | 2297.06 | 459 / 459 | 100% | 31.73 | 1116 / 1118 |
| bladder | 100% | 2284.57 | 21 / 21 | 100% | 28.17 | 503 / 504 |
| skin | 100% | 3251.74 | 1809 / 1809 | 100% | 32.84 | 471 / 472 |
| brain | 100% | 2578.59 | 2634 / 2642 | 100% | 34.25 | 705 / 705 |
| thymus | 100% | 1811.78 | 653 / 653 | 100% | 18.92 | 603 / 605 |
| liver | 100% | 1295.68 | 226 / 226 | 99% | 15.25 | 403 / 406 |
| lung | 99% | 1716.80 | 573 / 578 | 100% | 27.36 | 1154 / 1155 |
| kidney | 100% | 1428.60 | 89 / 89 | 97% | 15.29 | 873 / 901 |
| adrenal gland | 100% | 1760.83 | 258 / 258 | 95% | 21.81 | 219 / 230 |
| adipose | 100% | 2190.53 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 30.58 | 29 / 29 |
| muscle | 100% | 3113.98 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 1651.24 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 25.65 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 19.39 | 1 / 1 |
| blood vessel | 100% | 1859.27 | 1333 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 99% | 23.93 | 79 / 80 |
| heart | 96% | 1689.24 | 828 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 66% | 1573.64 | 616 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006412 | Biological process | translation |
| GO_0006432 | Biological process | phenylalanyl-tRNA aminoacylation |
| GO_0051290 | Biological process | protein heterotetramerization |
| GO_0009328 | Cellular component | phenylalanine-tRNA ligase complex |
| GO_0005829 | Cellular component | cytosol |
| GO_0016020 | Cellular component | membrane |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005524 | Molecular function | ATP binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0004826 | Molecular function | phenylalanine-tRNA ligase activity |
| GO_0000287 | Molecular function | magnesium ion binding |
| GO_0003723 | Molecular function | RNA binding |
| Gene name | FARSB |
| Protein name | Phenylalanine--tRNA ligase beta subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase beta subunit) (PheRS) Phenylalanine--tRNA ligase beta subunit (EC 6.1.1.20) |
| Synonyms | FRSB HSPC173 FARSLB |
| Description | |
| Accessions | ENST00000281828.8 [Q9NSD9-1] Q9BR63 Q9NSD9 |